Brainstorm Cell Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Brainstorm Cell Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $12k | 53k | 0.23 |
| 2024-06-30 | $9.8k | 29k | 0.34 |
| 2024-03-31 | $17k | 29k | 0.57 |
| 2023-12-31 | $8.1k | 30k | 0.27 |
| 2023-09-30 | $8.0k | 40k | 0.20 |
| 2023-06-30 | $77k | 37k | 2.06 |
| 2022-12-31 | $33k | 20k | 1.64 |
| 2022-09-30 | $108k | 20k | 5.29 |
| 2022-06-30 | $50k | 18k | 2.77 |
| 2022-03-31 | $88k | 16k | 5.41 |
| 2021-12-31 | $70k | 19k | 3.75 |
| 2021-09-30 | $71k | 13k | 5.41 |
| 2021-06-30 | $68k | 13k | 5.29 |
| 2021-03-31 | $116k | 31k | 3.80 |
| 2020-12-31 | $466k | 103k | 4.54 |
| 2020-09-30 | $1.1M | 68k | 16.93 |
| 2020-06-30 | $666k | 59k | 11.23 |
| 2020-03-31 | $117k | 16k | 7.52 |
| 2019-12-31 | $21k | 5.0k | 4.20 |
| 2019-09-30 | $20k | 5.0k | 4.00 |
| 2019-06-30 | $20k | 5.1k | 3.90 |
| 2019-03-31 | $22k | 5.0k | 4.40 |
| 2018-12-31 | $18k | 5.0k | 3.60 |
| 2018-09-30 | $56k | 15k | 3.85 |
| 2018-06-30 | $56k | 14k | 3.90 |
| 2018-03-31 | $45k | 14k | 3.14 |
| 2017-12-31 | $44k | 11k | 3.88 |
| 2017-06-30 | $21k | 5.0k | 4.20 |
| 2017-03-31 | $21k | 5.0k | 4.20 |
| 2016-12-31 | $10k | 4.0k | 2.50 |
| 2016-09-30 | $10k | 4.0k | 2.50 |